Joanne Casey

Jo Casey, Royal College of Podiatry

Joanne Casey is podiatrist who has specialised in the foot in diabetes with a research interest in the renal foot.

She has worked within NHS primary, secondary, tertiary care teams and within independent practice settings. She has spent half of her 20 year career working with the team in The Mike Edmonds Foot Clinic at Kings College Hospital, London.

She has a strong passion for community health, encouraging social prescribing and collaborative partnerships to provide individuals with personalised care in order to prevent tissue loss and limb amputation.

Joanne is currently the Podiatry Project Officer at The Royal College of Podiatry, Visiting Podiatry Lecturer at The University of Southampton and co-vice chair of the Legs Matter coalition.

Presentions at The Society of Tissue Viability 2022 Conference

Managing the ‘at risk’ foot in patients with renal disease


After attending this session, persons will be able to:

  • Have refreshed their knowledge of the anatomy and physiology of the kidney
  • Better understand CKD and implications of impaired kidney function on the foot
  • Understand how research has shaped our understanding of CKD in the ‘at risk’ foot.
  • Be aware of the implications of clinical practice
  • Be able to offer further support to patients living with CKD


Renal disease has in recent years been recognised as a major contributor to the poor health of the foot and lower limb.  The kidney is an organ with some of the most complicated and intricate structures within the body which are responsible for cleansing the blood of toxins and transforming the waste into urine for excretion.  There are usually no signs of chronic kidney disease (CKD) in the early stages and so diagnosis is often noted either by chance or when side effects become obvious.  It can be a common condition which is often associated with getting older and as society finds itself with an aging population the associated pathological changes from the effects of renal disease, may begin to shape our healthcare services.  In NICE guidance updated in 2016 within the foot risk stratification for those people living with diabetes, CKD 3A and above is a risk factor that could elevate a patient from moderate to high risk.  This lift in risk status carries not only a more complex understanding of the foot and lower limb from an experienced health care professional but also more timely management and support to ensure best practice for patient care. Some of the first noted effects of CKD are within the lower limb and foot and this puts podiatric medicine as valuable resource not only in the diagnosis of CKD but also with the on-going management of complications that maybe seen within the lower limb.

How can we improve antimicrobial stewardship in wound care? Panel debate


After attending this session, persons will be able to:

  • Have a better understanding of the principles of AMS
  • Recognise the importance of AMS within wound care
  • Be able to identify the challenges in promoting AMS in practice
  • Be able to recognise their role in AMS
  • Have a greater understanding of how AMS can be conducted when caring for patients with infected wounds


With the growing global problem of antimicrobial resistance, it is crucial that clinicians use antibiotics wisely, which largely means following the principles of Antimicrobial Stewardship (AMS). This is a multi-modal approach that includes infection prevention and the promotion of judicious use of antimicrobials to preserve their future effectiveness, while also improving the safety and quality of patient care (NICE, 2014; NICE 2015).

All open wounds will be colonised with bacteria, but antibiotic therapy is only required for those that are clinically infected. It is known that this guidance isn’t always followed, with some patients receiving multiple courses of antibiotics for wound infections that have been misdiagnosed.

In addition, topical antimicrobials are being increasingly used in wound care creating concerns of micro-organisms developing resistance to these therapies as well.

This panel discussion will explore some of the challenges in managing wounds at risk of infection and will provide delegates with a greater understanding of why AMS is important, who should be involved in AMS and what decisions/ action should be taken when caring for patients with infected wounds.